引用次数
引用: 3,433
H-指数: 35
I10-指数 : 78
出版物: 176
Preclinical Assessment of Strategies for Enhancement of Metaiodobenzylguanidine Therapy of Neuroendocrine Tumors
Rob J. Mairs , Marie Boyd
Seminars in Nuclear Medicine 41 ( 5) 334 -344
13
2011
Optimizing MIBG therapy of neuroendocrine tumors: preclinical evidence of dose maximization and synergy
Rob J. Mairs , Marie Boyd
Nuclear Medicine and Biology 35 ( 1)
18
2008
Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma.
Mark N. Gaze , Yen-Ch'ing Chang , Glenn D. Flux , Rob J. Mairs
Cancer Biotherapy and Radiopharmaceuticals 20 ( 2) 195 -199
156
2005
Development of a Real-Time Polymerase Chain Reaction Assay for Prediction of the Uptake of Meta-[131I]iodobenzylguanidine by Neuroblastoma Tumors
Berthe L van Eck-Smit , Deborah A Tweddle , Rob J Mairs , Caroline Ellershaw
Clinical Cancer Research 9 ( 9) 3338 -3344
70
2003
New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.
Rob J Mairs , MR Zalutsky
British Journal of Cancer 72 ( 1) 250 -250
5
1995
1044. Radioprotective Gene Therapy through Retroviral Expression of Manganese Superoxide Dismutase
Thomas D Southgate , Victoria Sheard , Michael D Milsom , Rob J Mairs
Molecular Therapy 11 ( S1) S404 -S404
2005
Molecular Oncology, Markers, Clinical Correlates-Development of a Real-Time Polymerase Chain Reaction Assay for Prediction of the Uptake of Meta-(131I) iodobenzylguanidine by Neuroblastoma Tumors.
Sean Carlin , Rob J Mairs , Anthony G McCluskey , Deborah A Tweddle
Clinical Cancer Research 9 ( 9) 3338 -3344
2003
Evaluation of Melanin-Targeted Radiotherapy in Combination with Radiosensitizing Drugs for the Treatment of Melanoma
John W Babich , Robert J Mairs , Colin Rae , Marie Boyd
Cancer and Oncology Research 2 ( 4) 58 -67
1
2014
Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill.
Marie Boyd , Robert J Mairs , Susan C Mairs , Lesley Wilson
Oncogene 20 ( 53) 7804 -7808
30
2001
Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen species
Colin Rae , Mathias Tesson , John W Babich , Marie Boyd
EJNMMI research 3 ( 1) 73 -73
8
2013
Radiosensitization of prostate cancer cells by 2-deoxyglucose
Colin Rae , Chun HC Sey , Robert J Mairs
Madridge Journal of Oncogenesis 2 ( 1) 30 -34
3
2018
Modelling the enhancement of fractionated radiotherapy by gene transfer to sensitize tumour cells to radiation
Thomas E Wheldon , Robert J Mairs , Roy P Rampling , Ann Barrett
Radiotherapy and Oncology 48 ( 1) 5 -13
17
1998
Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models.
Sean Carlin , Shona H Cunningham , Marie Boyd , Anthony G McCluskey
Cancer Gene Therapy 7 ( 12) 1529 -1536
57
2000
Sodium-iodide symporter (NIS)-mediated accumulation of [211At]astatide in NIS-transfected human cancer cells
Sean Carlin , Robert J Mairs , Phil Welsh , Michael R Zalutsky
Nuclear Medicine and Biology 29 ( 7) 729 -739
39
2002
Molecular radiotherapy with Matin: iodine-131 meta-iodobenzylguanidine and Topotecan in neuroblastoma. Toxicity and survival in patients with relapsed or refractory neuroblastoma. A Siopen Study
Mark N Gaze , Jamshed B Bomanji , Penelope R Brock , Glenn D Flux
Pediatric Blood & Cancer 59 ( 6) 1058 -1058
1
2012
Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with α-, β-, and Auger electron–emitting radionuclides
Marie Boyd , Susan C Ross , Jennifer Dorrens , Natasha E Fullerton
Journal of nuclear medicine 47 ( 6) 1007 -1015
203
2006
Radiation quality‐dependent bystander effects elicited by targeted radionuclides
Marie Boyd , Annette Sorensen , Anthony G McCluskey , Robert J Mairs
Journal of Pharmacy and Pharmacology 60 ( 8) 951 -958
55
2008
Principles of molecular targeting for radionuclide therapy
Francesco Bartoli , William C Eckelman , Marie Boyd , Robert J Mairs
Springer International Publishing 41 -93
2022
BASIC SCIENCE INVESTIGATIONS-Radiation-Induced Biologic Bystander Effect Elicited In Vitro by Targeted Radiopharmaceuticals Labeled with a-, b-, and Auger Electron-Emitting Radionuclides
Marie Boyd , Susan C Ross , Jennifer Dorrens , Natasha E Fullerton
Journal of Nuclear Medicine 47 ( 6) 1007 -1015
2006
THE ROLE OF PARP-1 IN THE CELLULAR RESPONSE TO LOW DOSE RADIATION Anthony Chalmers*, Mick Woodcock, Peter Johnston. Gray Cancer Institute, Northwood UK
Marie Boyd , Anne Livingstone , Kate Hughes , Lesley Wilson
British Journal of Cancer 88 ( 1) S11 -S24
2003